Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Protagonist Therapeutics Inc (NQ: PTGX )

47.12 USD +0.13 (+0.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 362,597
Open 47.61
Bid (Size) 47.05 (8)
Ask (Size) 47.13 (2)
Prev. Close 46.99
Today's Range 46.66 - 49.00
52wk Range 14.16 - 48.70
Shares Outstanding 43,945,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Protagonist Therapeutics Announces Amendment of Agreement with Janssen Biotech for the Continued Development and Commercialization of IL-23 Antagonists
Amended Agreement Provides for Janssen to Lead Worldwide Development and Commercialization of Multiple Compounds in Parallel and Expands Range of Indications Contemplated 
From PR Newswire
Protagonist Therapeutics Reports Granting of Inducement Award
Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on June 30, 2021, it issued an inducement award to Patrick Smith, the Company's recently hired Vice President, Quality Assurance, in... 
From PR Newswire

Performance

YTD
+140.41%
+140.41%
1 Month
+7.41%
+7.41%
3 Month
+59.14%
+59.14%
6 Month
+128.07%
+128.07%
1 Year
+190.15%
+190.15%

More News

Read More
Protagonist Therapeutics, Inc. Announces Closing of $132.2 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
From PR Newswire
Interesting PTGX Put And Call Options For August 20th
Tags Stocks
From Market News Video
Stocks That Hit 52-Week Highs On Thursday
Tags DG WCN PFHD
From Benzinga
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
Tags ISRG BNTX NAUT
From Benzinga
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Tags Top Stories ISRG Small Cap
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
Tags PLYM LNT REXR
From Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
Tags PLXP Biotech TECH
From Benzinga
The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
Tags CDTX KRYS PTGX
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
Tags SWBI 52 Week Highs NMCO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.